Prenetics Global
Yahoo Finance • 14 days ago
Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End
1st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR1 of over 3,100% Prenetics increases FY2025 revenue guidance range of $85 – $100 million Prenetics provides update on... Full story
Yahoo Finance • 18 days ago
Prenetics’ IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open Championship
Aryna Sabalenka becomes first woman to defend US Open title in more than a decadeAI-powered Aryna Sabalenka ad goes viral with 233M Instagram views and Times Square billboard during US OpenIM8 achieves 300,000+ customer purchases and 6 mil... Full story
Yahoo Finance • 2 months ago
UK's August 2025 Penny Stocks To Watch
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weak trade data from China and global economic uncertainties. Despite these broader market pressures, oppo... Full story
Yahoo Finance • 3 months ago
World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder
Aryna Sabalenka becomes first-ever current athlete shareholder in Prenetics, listed on the NASDAQ: (PRE) In just six months, IM8 is one of the fastest growing supplement brands in the world, generating an extraordinary US$50m+ Annual Recur... Full story
Yahoo Finance • 3 months ago
World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder
Aryna Sabalenka becomes first-ever current athlete shareholder in Prenetics, listed on the NASDAQ: (PRE) In just six months, IM8 is one of the fastest growing supplement brands in the world, generating an extraordinary US$50m+ Annual Recur... Full story
Yahoo Finance • 3 months ago
Prenetics stock steady as Cantor reiterates rating on divestiture news
Investing.com - Cantor Fitzgerald reiterated its Overweight rating and $14.00 price target on Prenetics (NASDAQ:PRE) following the company’s recent business divestiture and cryptocurrency investment. The stock, currently trading at $8.96,... Full story
Yahoo Finance • 3 months ago
Prenetics Global announces bitcoin treasury with $20M BTC purchase
* Prenetics Global Limited (NASDAQ:PRE [https://seekingalpha.com/symbol/PRE]) completed a $20M Bitcoin purchase (187.42 BTC at ~$106,712/BTC). * Andy Cheung, ex-COO of OKEx, joins the board of directors to oversee Prenetics' Bitcoin st... Full story
Yahoo Finance • 3 months ago
# Prenetics becomes first healthcare firm to acquire bitcoin for treasury
CHARLOTTE, N.C. - Prenetics Global Limited (NASDAQ:PRE), a healthcare company with a market capitalization of $97.89 million, has purchased 187.42 bitcoin worth $20 million at an average price of $106,712 per bitcoin, becoming the first he... Full story
Yahoo Finance • 3 months ago
Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board
- Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation - Following strategic divestiture, Prenetics leverages strengthened $117M balance... Full story
Yahoo Finance • 3 months ago
Prenetics Global divests ACT Genomics for $46M
* Prenetics Global (NASDAQ:PRE [https://seekingalpha.com/symbol/PRE]) announced the divestment of its majority stake in ACT Genomics to Delta Electronics in a deal valued at up to $71.78Mn. * Prenetics will receive ~$46M in cash, boost... Full story
Yahoo Finance • 3 months ago
Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction
Bolsters Prenetics’ pro-forma cash reserves to approximately US$86 million, and pro-forma cash and short-term assets to approximately US$117 million Prenetics simplifies investment thesis as company focuses on high-growth consumer health b... Full story
Yahoo Finance • 3 months ago
Pensana to issue equity for incentive awards to employees
LONDON - Pensana Plc (LSE:PRE) announced it will issue 3,943,750 new ordinary shares related to employee incentive programs, according to a press release statement issued Wednesday. The equity issuance includes 1,043,750 shares for vested... Full story
Yahoo Finance • 7 months ago
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024 Cash and short-term assets of $84.8 million as of December 31, 2024 Provides first quarter and full year 2025 guidance Projects... Full story
Yahoo Finance • 7 months ago
Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve
CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M in Bitcoin, Solana and H tokens, supported by strong balance sheetPrenetics advances Decentra... Full story
Yahoo Finance • 2 years ago
Prenetics Announces Third Quarter 2023 Financial Results
HONG KONG, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced financial results for the third quarter ended Septembe... Full story
Yahoo Finance • 2 years ago
Prenetics Global Limited Announces Reverse Stock Split
HONG KONG, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading-genomics-driven health sciences company today announced that it will proceed with a reverse stock split of its outstanding ordinary shares at... Full story
Yahoo Finance • 2 years ago
Prenetics Announces Second Quarter 2023 Financial Results
HONG KONG, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced financial results for the second quarter ended June 3... Full story
Yahoo Finance • 2 years ago
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening
(Prof. Dennis Lo and Danny Yeung at Signing Ceremony) - Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics which is supported by the InnoHK In... Full story
Yahoo Finance • 3 years ago
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
LONDON and HONG KONG, March 14, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision oncology company, today announced financial results for the fourth quarter a... Full story
Yahoo Finance • 3 years ago
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
LONDON and HONG KONG, March 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the ‘SAB’) to p... Full story
